Cargando…

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Bladder cancer is one of the leading causes of death worldwide. About 75% of patients initially present with non-muscle-invasive disease, while the rest presents with primary muscle-invasive disease. Up to a third of non-muscle-invasive bladder cancers progresses into secondary muscl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pones, Mario, D’Andrea, David, Mori, Keiichiro, Abufraj, Mohammad, Moschini, Marco, Comperat, Eva, Shariat, Shahrokh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160701/ https://www.ncbi.nlm.nih.gov/pubmed/34065365 http://dx.doi.org/10.3390/cancers13102496

Ejemplares similares

ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
por: Mori, Keiichiro, et al.
Publicado: (2022)

Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2021)

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response
por: Grubmüller, Bernhard, et al.
Publicado: (2021)

The Impact of Surgical Waiting Time on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Systematic Review
por: Nowak, Łukasz, et al.
Publicado: (2022)

How to optimally manage elderly bladder cancer patients?
por: Soria, Francesco, et al.
Publicado: (2016)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Typhus Never: Its Apparent Origin DeNovo
por: Quill, R. H.
Publicado: (1895)

A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
por: Mari, Andrea, et al.
Publicado: (2018)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

denovo-db: a compendium of human de novo variants
por: Turner, Tychele N., et al.
Publicado: (2017)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
por: Soria, Francesco, et al.
Publicado: (2019)

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
por: Grossmann, Nico C, et al.
Publicado: (2021)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

IDP-denovo: de novo transcriptome assembly and isoform annotation by hybrid sequencing
por: Fu, Shuhua, et al.
Publicado: (2018)

DenovoProfiling: A webserver for de novo generated molecule library profiling
por: Liu, Zhihong, et al.
Publicado: (2022)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
por: Mari, Andrea, et al.
Publicado: (2017)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Denovo assembly and characterization of tissue-specific transcriptome in the endangered golden mahseer, Tor putitora
por: Barat, Ashoktaru, et al.
Publicado: (2015)

Gene4Denovo: an integrated database and analytic platform for de novo mutations in humans
por: Zhao, Guihu, et al.
Publicado: (2020)

Clinical onset of CNS demyelinating disease after COVID-19 vaccination: denovo disease?
por: Gernert, J.A., et al.
Publicado: (2022)

Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2023)

EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases
por: Mao, Fengbiao, et al.
Publicado: (2018)

Arthroscopic Technique for Treating Patella and Femoral Condyle Lesions With DeNovo Natural Tissue Allograft
por: Truntzer, Jeremy, et al.
Publicado: (2019)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

HGA: denovo genome assembly method for bacterial genomes using high coverage short sequencing reads
por: Al-okaily, Anas A.
Publicado: (2016)

The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Zheng, Weitao, et al.
Publicado: (2022)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020)

Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review
por: Aydh, Abdulmajeed, et al.
Publicado: (2020)

Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies
por: Compérat, Eva, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6kgvctlso0cebkkv0nngdmnp27